GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 767 filers reported holding GLAXOSMITHKLINE PLC in Q1 2021. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $3,477,000 | +209.3% | 79,884 | +209.5% | 0.16% | +194.3% |
Q1 2022 | $1,124,000 | +244.8% | 25,809 | +248.9% | 0.05% | +165.0% |
Q4 2021 | $326,000 | -70.9% | 7,397 | -75.7% | 0.02% | -83.2% |
Q4 2020 | $1,120,000 | -79.1% | 30,435 | -76.2% | 0.12% | -68.7% |
Q1 2019 | $5,353,000 | +913.8% | 128,086 | +760.9% | 0.38% | +555.2% |
Q4 2017 | $528,000 | +120.9% | 14,879 | +140.0% | 0.06% | +52.6% |
Q4 2016 | $239,000 | -91.6% | 6,200 | -91.2% | 0.04% | -84.8% |
Q4 2015 | $2,835,000 | – | 70,267 | – | 0.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |